journal article·2023-03-06

MXene-Based Dual Functional Nanocomposite with Photothermal Nanozyme Catalytic Activity to Fight Bacterial Infections

Haitao Yuan, Xiaoping Hong, Huan Ma, Chunjin Fu, Yudong Guan, Wei Huang, Jingbo Ma, Peng Xia, Min Cao, Liuhai Zheng, Xiaolong Xu, Chengchao Xu, Dongzhou Liu, Zhijie Li, Qingshan Geng, Jigang Wang

ACS Materials Letters· Volume 5· Issue 3
Publisher page

Abstract

Bacterial infections are common complications for diabetic wounds and represent a considerable challenge for wound therapy. Diabetic wound infections differ from those of normal wounds. Owing to the special microenvironment around them, diabetic wounds are more susceptible to infection and are difficult to heal. Nanozymes are of great significance to treat diabetic wound bacterial infections through unique catalytic activities, particularly for controlling drug-resistant bacteria. However, their intrinsically low catalytic activity largely restricts their bactericidal function. Therefore, it is crucial to design and develop novel antibacterial modalities with multiple mechanisms of action. In this study, we design and synthesize a CeO 2 /Nb 2 C nanocomposite with dual functions of peroxidase activity and an excellent near-infrared (NIR) photothermal property. Under 808 nm laser irradiation, the CeO 2 /Nb 2 C nanocomposite produced a photothermal antibacterial effect and simultaneously displayed a synergistic enzyme catalytic property, thereby killing bacteria in a sustained manner with more than 80% sterilization ratio. The CeO 2 /Nb 2 C nanocomposite could accelerate the recovery of diabetic wounds when the skin lesions infected with methicillin-resistant Staphylococcus aureus (MRSA) were irradiated with an 808 nm laser in a diabetic mouse model. An RNA sequencing assay was used to profile the dynamic transcriptome of MRSA. The data set reveals that bacteria experience dysfunction in energy metabolism, cell morphology, and oxidative stress systems during the treatment with CeO 2 /Nb 2 C nanocomposite under NIR irradiation, which further affects their survival. Moreover, the CeO 2 /Nb 2 C nanocomposite exhibits good biosafety in vitro and in vivo, which indicates their potency as antibacterial agents. This study provides a novel antibacterial strategy by the combination of the catalytic sterilization with the NIR photothermal activity of nanozymes for the effective treatment of MRSA-related diabetic wound infection.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Nephrology, Shenzhen Key Laboratory of Kidney Diseases, and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, P.R. China

Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University, Guangzhou 510632, P.R. China

Department of Rheumatology and Immunology, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People’s Hospital, Shenzhen, Guangdong 518020, P.R. China

Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510050, P.R. China

School of Chemical Engineering and Technology, Sun Yat-sen University, Zhuhai 519082, P.R. China

Department of Hepatobiliary& Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430062, Hubei, P.R. China

Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing100700, P.R. China

Department of Geriatrics, Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, P.R. China

Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, P.R. China

Funding

Ministry of Science and Technology of the People's Republic of China · Science and Technology Foundation of Shenzhen City · China Postdoctoral Science Foundation · National Health Commission of the People's Republic of China · China Academy of Chinese Medical Sciences · National Natural Science Foundation of China · Shenzhen Government · Guangdong Provincial People's Hospital · Shenzhen key Laboratory of Kidney Diseases · Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties · Basic and Applied Basic Research Foundation of GuangDong Province · International Science and Technology Cooperation for Shenzhen Technology Innovation Plan · Fundamental Research Funds for the Central Public Welfare Research Institutes

References (44)

Show source-provided references
1. 10.1038/s41467-020-15735-610.1038/s41467-020-15735-6 ↗
2. 10.1038/s41564-020-0722-010.1038/s41564-020-0722-0 ↗
3. 10.1038/s41581-020-0278-510.1038/s41581-020-0278-5 ↗
4. 10.1021/acsnano.8b0933610.1021/acsnano.8b09336 ↗
5. 10.1021/nn501640q10.1021/nn501640q ↗
6. 10.1038/nmat454210.1038/nmat4542 ↗
7. 10.1038/s41467-019-14199-710.1038/s41467-019-14199-7 ↗
8. 10.1021/cr200263w10.1021/cr200263w ↗
9. 10.1021/acsami.9b1778310.1021/acsami.9b17783 ↗
10. 10.1016/j.biomaterials.2020.12059810.1016/j.biomaterials.2020.120598 ↗
11. 10.1039/D1MH00508A10.1039/D1MH00508A ↗
12. 10.1002/advs.20220073210.1002/advs.202200732 ↗
13. 10.1002/adma.20210257010.1002/adma.202102570 ↗
14. 10.1016/j.biomaterials.2012.01.03510.1016/j.biomaterials.2012.01.035 ↗
15. 10.1002/smll.20120310610.1002/smll.201203106 ↗
16. 10.1002/adma.20210314810.1002/adma.202103148 ↗
17. 10.1002/adma.20170328410.1002/adma.201703284 ↗
18. 10.1002/smll.20210094610.1002/smll.202100946 ↗
19. 10.1002/adhm.20170139410.1002/adhm.201701394 ↗
20. 10.1021/acsami.9b1359810.1021/acsami.9b13598 ↗
21. 10.1021/acsnano.0c0804510.1021/acsnano.0c08045 ↗
22. 10.1002/smll.20220085710.1002/smll.202200857 ↗
23. 10.1007/s40820-022-00901-w10.1007/s40820-022-00901-w ↗
24. 10.1007/s40820-022-00848-y10.1007/s40820-022-00848-y ↗
25. 10.1039/C7TB01689A10.1039/C7TB01689A ↗
26. 10.1021/acsbiomaterials.8b0048910.1021/acsbiomaterials.8b00489 ↗
27. 10.1002/adhm.20210003310.1002/adhm.202100033 ↗
28. 10.1016/j.biomaterials.2020.12061410.1016/j.biomaterials.2020.120614 ↗
29. 10.1002/smll.20220216110.1002/smll.202202161 ↗
30. 10.1021/acsami.7b0522710.1021/acsami.7b05227 ↗
31. 10.1021/acsami.0c0573210.1021/acsami.0c05732 ↗
32. 10.1016/j.freeradbiomed.2011.08.02510.1016/j.freeradbiomed.2011.08.025 ↗
33. 10.1021/nn300934k10.1021/nn300934k ↗
34. 10.1021/jp200686k10.1021/jp200686k ↗
35. 10.1039/C5RA14061G10.1039/C5RA14061G ↗
36. 10.1021/nn101390x10.1021/nn101390x ↗
37. 10.1021/acsmaterialslett.0c0030410.1021/acsmaterialslett.0c00304 ↗
38. 10.1021/jacsau.2c0032110.1021/jacsau.2c00321 ↗
39. 10.1128/JB.01524-0610.1128/JB.01524-06 ↗
40. 10.1080/09168451.2020.179747010.1080/09168451.2020.1797470 ↗
41. 10.1007/s13738-012-0185-110.1007/s13738-012-0185-1 ↗
42. 10.1007/s00726-019-02757-810.1007/s00726-019-02757-8 ↗
43. 10.1186/1471-2164-7-110.1186/1471-2164-7-1 ↗
44. 10.1128/JB.183.16.4779-4785.200110.1128/JB.183.16.4779-4785.2001 ↗